Muhamed-Kheir Taha Selected Research

Meningococcal Infections

12/2022	Product review on the IMD serogroup B vaccine Bexsero®.
1/2022	Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
1/2022	Correlates of protection for meningococcal surface protein vaccines: lessons from the past.
12/2021	Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France.
11/2020	Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
10/2020	Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex.
9/2020	Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice.
1/2020	Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland.
1/2019	Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.
2/2018	MenB-FHbp Meningococcal Group B Vaccine (Trumenba®): A Review in Active Immunization in Individuals Aged ≥ 10 Years.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muhamed-Kheir Taha Research Topics

Disease

30	Meningococcal Infections 12/2022 - 10/2003
17	Infections 07/2021 - 05/2003
11	Meningitis 03/2021 - 03/2007
4	Sepsis (Septicemia) 09/2020 - 01/2011
4	Bacterial Meningitis 05/2014 - 03/2008
3	Meningococcal Meningitis 02/2015 - 03/2006
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 07/2004
2	Hereditary Complement Deficiency Diseases 01/2019 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2018 - 04/2017
1	Whooping Cough (Pertussis) 01/2022
1	Cicatrix (Scar) 09/2021
1	Intellectual Disability (Idiocy) 09/2021
1	Chickenpox 08/2021
1	Exanthema (Rash) 10/2018
1	Meningism (Meningismus) 01/2018
1	Urethritis 01/2016
1	Inflammation (Inflammations) 09/2015
1	Viral Meningitis 05/2014
1	Bacteremia 09/2010
1	Wounds and Injuries (Trauma) 09/2009
1	Pneumonia (Pneumonitis) 12/2003
1	Superinfection 05/2003

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 12/2022 - 07/2004
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 10/2003
7	Transferrin (beta 2 Transferrin)IBA 09/2020 - 12/2007
7	Conjugate VaccinesIBA 03/2019 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2004
5	Complement System Proteins (Complement)IBA 01/2019 - 01/2016
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 03/2008
3	Meningococcal Vaccines (Meningococcal Vaccine)IBA 01/2022 - 07/2007
3	Complement Factor H (Factor H)IBA 09/2020 - 01/2014
3	CytokinesIBA 01/2020 - 09/2010
3	Carrier Proteins (Binding Protein)IBA 01/2017 - 01/2014
2	Polysaccharides (Glycans)IBA 03/2021 - 12/2013
2	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2020 - 04/2013
2	Third Generation CephalosporinsIBA 10/2018 - 09/2009
2	CarbonIBA 01/2016 - 01/2009
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2016 - 09/2015
2	human CFH proteinIBA 01/2016 - 01/2016
2	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2016 - 03/2006
2	Interleukin-10 (Interleukin 10)IBA 09/2015 - 05/2003
2	AntibodiesIBA 05/2006 - 07/2004
1	Pertussis ToxinIBA 01/2022
1	Pertussis VaccineIBA 01/2022
1	CEACAM1 ProteinIBA 09/2020
1	AntigensIBA 01/2019
1	eculizumab FDA Link 01/2019
1	methylallyl trisulfide (MATS)IBA 01/2019
1	Biological ProductsIBA 01/2018
1	GadoliniumIBA 01/2018
1	Combined VaccinesIBA 01/2017
1	4CMenB vaccineIBA 04/2016
1	PhosphoenolpyruvateIBA 01/2016
1	phosphocarrier protein HPrIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	SugarsIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	Peptides (Polypeptides)IBA 08/2015
1	Lipocalin-2IBA 05/2014
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2014
1	Type I Tumor Necrosis Factor ReceptorsIBA 12/2011
1	LactamsIBA 10/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2011
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2010
1	beta Lactam AntibioticsIBA 09/2009
1	CarbohydratesIBA 07/2004
1	HaptensIBA 07/2004
1	Phosphorylcholine (Phosphocholine)IBA 07/2004
1	DNA (Deoxyribonucleic Acid)IBA 12/2003
1	AgarIBA 11/2003
1	Capsules (Microcapsules)IBA 05/2003
1	Interferon-gamma (Interferon, gamma)IBA 05/2003
1	Virulence Factors (Pathogenicity Factors)IBA 05/2003

Therapy/Procedure

6	Therapeutics 01/2019 - 09/2009
1	Surgical Amputation (Amputations) 09/2021
1	Chemoprevention 10/2003